↓ Skip to main content

Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices

Overview of attention for article published in Frontiers in oncology, December 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
10 X users

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices
Published in
Frontiers in oncology, December 2022
DOI 10.3389/fonc.2022.1015200
Pubmed ID
Authors

Pattanaik Smita, Patil Amol Narayan, Kumaravel J, Prakash Gaurav

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 14%
Student > Ph. D. Student 6 14%
Student > Postgraduate 3 7%
Professor 1 2%
Student > Doctoral Student 1 2%
Other 2 5%
Unknown 25 57%
Readers by discipline Count As %
Medicine and Dentistry 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Chemistry 2 5%
Engineering 2 5%
Nursing and Health Professions 1 2%
Other 4 9%
Unknown 26 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2023.
All research outputs
#6,799,534
of 26,617,918 outputs
Outputs from Frontiers in oncology
#2,256
of 23,380 outputs
Outputs of similar age
#126,099
of 502,136 outputs
Outputs of similar age from Frontiers in oncology
#109
of 1,480 outputs
Altmetric has tracked 26,617,918 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 23,380 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 502,136 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 1,480 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.